160 related articles for article (PubMed ID: 37772487)
1. Pulmonary lymphangitis carcinomatosis: A peculiar presentation clustering in MET-amplified gastric cancer.
Zhang Z; Yu Y; Xie T; Qi C; Zhang X; Shen L; Peng Z
Cancer Med; 2023 Oct; 12(19):19583-19594. PubMed ID: 37772487
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary lymphangitis carcinomatosis: systematic review and meta-analysis of case reports, 1970-2018.
Klimek M
Postgrad Med; 2019 Jun; 131(5):309-318. PubMed ID: 30900501
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and diagnosis of pulmonary lymphangitic carcinomatosis].
Zhang K; Huang Y
Ai Zheng; 2006 Sep; 25(9):1127-30. PubMed ID: 16965655
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa.
Funakoshi T; Yasui H; Boku N; Fukutomi A; Yamazaki K; Machida N; Todaka A; Tsushima T; Yokota T; Onozawa Y; Kenmotsu H; Endo M
Jpn J Clin Oncol; 2014 Sep; 44(9):792-8. PubMed ID: 25057093
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary lymphangitic carcinomatosis in liver carcinoma: a rare case report and literature review.
Zhuang L; Liu X; Hu C; Zhang L; Jiang G; Wu J; Zheng S
World J Surg Oncol; 2014 Mar; 12():66. PubMed ID: 24669948
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature.
Moubax K; Wuyts W; Vandecaveye V; Prenen H
BMC Res Notes; 2012 Nov; 5():638. PubMed ID: 23158653
[TBL] [Abstract][Full Text] [Related]
7. [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis responding remarkably to combination chemotherapy of docetaxel, CDDP and S-1].
Ishikawa T; Oyamada H; Suzuki K; Matsuyama R; Isozaki Y; Okita M; Nagao Y; Kiyota K; Kokura S; Yoshikawa T
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2397-400. PubMed ID: 19098410
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary lymphangitic carcinomatosis].
Gao Z; Deng X; Cao Z
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):739-41. PubMed ID: 11480078
[TBL] [Abstract][Full Text] [Related]
9. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA
Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375
[TBL] [Abstract][Full Text] [Related]
10. High-level FGFR2 amplification is associated with poor prognosis and Lower response to chemotherapy in gastric cancers.
Hur JY; Chao J; Kim K; Kim ST; Kim KM; Klempner SJ; Lee J
Pathol Res Pract; 2020 Apr; 216(4):152878. PubMed ID: 32089408
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced gastric cancer with carcinomatous lymphangitis of the lung treated with docetaxel and S-1 combination chemotherapy].
Okamoto E; Takagi K; Tamura A; Kondo M; Hanada S; Sakuranaka H; Ochi J; Tanaka M; Tei S; Ichioka M; Shibayama T
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2247-9. PubMed ID: 24394074
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and
Jreige M; Dunet V; Letovanec I; Prior JO; Meuli RA; Beigelman-Aubry C; Schaefer N
J Nucl Med; 2020 Jan; 61(1):26-32. PubMed ID: 31227574
[TBL] [Abstract][Full Text] [Related]
13. Lymphangitis carcinomatosis of unknown origin presenting as severe pulmonary hypertension.
Maza I; Braun E; Plotkin A; Guralnik L; Azzam ZS
Am J Med Sci; 2004 May; 327(5):255-7. PubMed ID: 15166744
[TBL] [Abstract][Full Text] [Related]
14. HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.
Liu YJ; Shen D; Yin X; Gavine P; Zhang T; Su X; Zhan P; Xu Y; Lv J; Qian J; Liu C; Sun Y; Qian Z; Zhang J; Gu Y; Ni X
Br J Cancer; 2014 Mar; 110(5):1169-78. PubMed ID: 24518603
[TBL] [Abstract][Full Text] [Related]
15. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
16. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L
BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic lymphangitis carcinomatosis due to squamous cell lung carcinoma.
Gupta PR; Joshi N; Meena RC; Ali M
Indian J Chest Dis Allied Sci; 2005; 47(2):121-3. PubMed ID: 15832957
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with trastuzumab and crizotinib in metastatic gastric cancer harboring Her-2 amplification and c-MET amplification: A case report.
Liu M
Medicine (Baltimore); 2021 Sep; 100(36):e27017. PubMed ID: 34516491
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary tumour embolism and lymphangitis carcinomatosa: a case report and review of the literature.
Engel J; Auer J
J Cardiothorac Surg; 2022 May; 17(1):105. PubMed ID: 35525999
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET/CT: A case report.
Wang Y; Su M; Li L
Medicine (Baltimore); 2019 Oct; 98(41):e17446. PubMed ID: 31593099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
